From: Overexpression of MACC1 and Its significance in human Breast Cancer Progression
 | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
 | P-value | Hazard ratio (95% CI) | P-value | Hazard ratio (95% CI) |
Age | Â | Â | Â | Â |
 ≤45 | 0.202 | 0.719 (0.433-1.193) |  |  |
 >45 |  |  |  |  |
Menopausal status | 0.768 | 0.915 (0.508-1.648) | Â | Â |
Premenopausal | Â | Â | Â | Â |
Postmenopausal | Â | Â | Â | Â |
Tumor size (cm) | Â | Â | Â | Â |
 ≤2 | 0.000 | 3.479 (1.881-6.435) | 0.146 | 1.649(0.840-3.237) |
 >2 | ||||
Lymph node status | Â | Â | Â | Â |
 Negative | <0.001 | 5.424 (2.932-10.036) | <0.001 | 4.205(2.205-8.017) |
 Positive | ||||
ER | Â | Â | Â | Â |
 Positive | 0.012 | 0.519 (0.310-0.866) | 0.060 | 0.606(0.359-1.021) |
 Negative | ||||
PR | Â | Â | Â | Â |
 Positive | 0.020 | 0.528 (0.308-0.906) |  |  |
 Negative | ||||
ErbB-2 | Â | Â | Â | Â |
 Positive | 0.220 | 1.527 (0.777-3.004) |  |  |
 Negative | ||||
MACC1 expression | Â | Â | Â | Â |
 Positive | 0.000 | 3.021 (1.659-5.501) | 0.006 | 2.378(1.279-4.424) |
 Negative |